Timber Pharmaceuticals, Inc.
TMBR
TMBR was delisted on the 28th of November, 2023.
15 hedge funds and large institutions have $1.04M invested in Timber Pharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 7 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
1% more capital invested
Capital invested by funds: $1.03M → $1.04M (+$10K)
0.01% less ownership
Funds ownership: 4.26% → 4.24% (-0.01%)
12% less funds holding
Funds holding: 17 → 15 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$79.6K |
| 2 |
Barclays
London,
United Kingdom
|
+$17.9K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$16.4K |
| 4 |
BlackRock
New York
|
+$12.7K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$3.85K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$66K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$28.8K |
| 3 |
Jane Street
New York
|
-$21K |
| 4 |
Two Sigma Advisers
New York
|
-$17K |
| 5 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
-$5K |
TMBR Hedge Fund Activity: Q1 2022 in Review
15 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q1 2022, worth a combined $1.04M — up 0.97% from $1.03M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of TMBR and 5 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $79.6K. The largest seller was Virtu Financial, exiting entirely with an estimated $66K sold.
- 15 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q1 2022, down from 17 in Q4 2021.
- Funds reported $1.04M of Timber Pharmaceuticals, Inc. stock for Q1 2022, up 0.97% quarter-over-quarter.
- 5 funds opened new Timber Pharmaceuticals, Inc. positions in Q1 2022 and 7 closed out, a net change of -2 holders.
- The largest Timber Pharmaceuticals, Inc. buyer in Q1 2022 was Renaissance Technologies, an estimated $79.6K added.
- The largest Timber Pharmaceuticals, Inc. seller in Q1 2022 was Virtu Financial, an estimated $66K sold.
Based on aggregated 13F filings for Q1 2022.